Literature DB >> 24486672

Multiple coronary thrombi with cisplatin.

Kanber Ocal Karabay1, Omer Yildiz, Vedat Aytekin.   

Abstract

Testicular cancer is the most common malignancy in young men (15-29 years old). Combination therapy with bleomycin, etoposide, and cisplatin has been the standard first-line treatment for testicular metastatic disease. We present a case of multicoronary thrombi causing acute inferior myocardial infarction in a patient who recently received chemotherapy for testicular tumor.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24486672

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN： 1042-3931            Impact factor:   2.022


  6 in total

Review 1.  Arterial events in cancer patients-the case of acute coronary thrombosis.

Authors:  Ohad Oren; Joerg Herrmann
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 2.  Vascular Toxicities of Cancer Therapies: The Old and the New--An Evolving Avenue.

Authors:  Joerg Herrmann; Eric H Yang; Cezar A Iliescu; Mehmet Cilingiroglu; Konstantinos Charitakis; Abdul Hakeem; Konstantinos Toutouzas; Massoud A Leesar; Cindy L Grines; Konstantinos Marmagkiolis
Journal:  Circulation       Date:  2016-03-29       Impact factor: 29.690

Review 3.  Common Vascular Toxicities of Cancer Therapies.

Authors:  Joerg Herrmann
Journal:  Cardiol Clin       Date:  2019-08-26       Impact factor: 2.213

Review 4.  Optimal management of coronary artery disease in cancer patients.

Authors:  Xue-Jie Han; Jian-Qiang Li; Zulfiia Khannanova; Yue Li
Journal:  Chronic Dis Transl Med       Date:  2020-01-14

Review 5.  Myocardial Ischemia Related to Common Cancer Therapy-Prevention Insights.

Authors:  Minerva Codruta Badescu; Oana Viola Badulescu; Dragos Viorel Scripcariu; Lăcrămioara Ionela Butnariu; Iris Bararu-Bojan; Diana Popescu; Manuela Ciocoiu; Eusebiu Vlad Gorduza; Irina Iuliana Costache; Elena Rezus; Ciprian Rezus
Journal:  Life (Basel)       Date:  2022-07-12

Review 6.  Vascular toxic effects of cancer therapies.

Authors:  Joerg Herrmann
Journal:  Nat Rev Cardiol       Date:  2020-03-26       Impact factor: 32.419
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.